AI
Anthropic's AI discovers novel enzyme system in biology lab debut
The AI company claims Claude has identified a previously unknown genetic system with gene-editing capabilities similar to CRISPR, less than a year after launching its Bay Area biology lab.
TechCrunch — AI
Anthropic has declared early success with its wet biology lab, announcing the identification of a previously unknown enzyme system found in bacteriophage DNA that exhibits gene-editing properties akin to CRISPR, the well-established gene-editing technology. The company credits Claude, its AI model, with discovering the system, which can perform DNA manipulation operations including cutting, copying, and pasting.
The Discovery#
The enzyme system was identified in the genetic material of bacteriophages—viruses that attack bacteria. According to Anthropic, the system functions like CRISPR, a bacterial defense mechanism that has revolutionized genetic research. The company says Claude accomplished this identification in roughly 21 hours of computational effort, employing approximately 950 agents and consuming 210 million tokens to sift through biological data.
Context and Caution#
The announcement arrives amid a broader acknowledgment from AI industry leaders that current models pose safety risks requiring careful oversight. CEO Dario Amodei has publicly expressed concern that AI could facilitate bioterrorism, yet he simultaneously projects that AI will "cure most diseases in 5-10 years." This tension underscores the calculus driving Anthropic's investment in biological research.
Amodei noted that Stanford researchers previously discovered a related enzyme system, tempering claims of novelty. The broader scientific community will ultimately determine the significance and originality of Anthropic's finding.
Lab Operations and Safety Measures#
Anthropic's biology facility, established earlier this year, operates under strict safety protocols. The lab restricts work to lower biosafety risk levels (BSL-1 and BSL-2), avoids handling human pathogens, and crucially, keeps all experimental work in human hands rather than deploying Claude as an autonomous agent. "All of the lab work is performed by human scientists," Anthropic stated.
Wider Trend#
Anthropic's foray into biological research reflects a growing intersection between AI and life sciences. Stanford researchers have published work on AI and CRISPR gene therapy, UC San Francisco researchers have used AI to design novel enzymes, and Google deployed AlphaFold in 2020. However, Amodei left open the possibility of fully autonomous labs in the future, stating that while Claude might eventually safely control lab equipment independently, "we aren't doing that today."
